| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2125232 | European Journal of Cancer | 2010 | 7 Pages |
Abstract
The results suggest that oenocyanin may be a viable and economical alternative to anthocyanin-rich berry extracts for chemopreventive intervention. Akt and pErk might be suitable biomarkers of anthocyanin target organ efficacy.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Hong Cai, Timothy H. Marczylo, Nicole Teller, Karen Brown, William P. Steward, Doris Marko, Andreas J. Gescher,